95 related articles for article (PubMed ID: 18230052)
1. New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination.
Bar EE; Stearns D
Expert Opin Investig Drugs; 2008 Feb; 17(2):185-95. PubMed ID: 18230052
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling promotes medulloblastoma survival via Bc/II.
Bar EE; Chaudhry A; Farah MH; Eberhart CG
Am J Pathol; 2007 Jan; 170(1):347-55. PubMed ID: 17200206
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A
Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076
[TBL] [Abstract][Full Text] [Related]
5. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
6. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice.
Sanchez P; Ruiz i Altaba A
Mech Dev; 2005 Feb; 122(2):223-30. PubMed ID: 15652709
[TBL] [Abstract][Full Text] [Related]
8. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
[No Abstract] [Full Text] [Related]
9. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
Tremblay MR; Nevalainen M; Nair SJ; Porter JR; Castro AC; Behnke ML; Yu LC; Hagel M; White K; Faia K; Grenier L; Campbell MJ; Cushing J; Woodward CN; Hoyt J; Foley MA; Read MA; Sydor JR; Tong JK; Palombella VJ; McGovern K; Adams J
J Med Chem; 2008 Nov; 51(21):6646-9. PubMed ID: 18842035
[TBL] [Abstract][Full Text] [Related]
10. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
Romer J; Curran T
Cancer Res; 2005 Jun; 65(12):4975-8. PubMed ID: 15958535
[TBL] [Abstract][Full Text] [Related]
11. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
[TBL] [Abstract][Full Text] [Related]
12. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of medulloblastoma and current treatment outlook.
Jozwiak J; Grajkowska W; Wlodarski P
Med Res Rev; 2007 Nov; 27(6):869-90. PubMed ID: 17089411
[TBL] [Abstract][Full Text] [Related]
14. Past, current and future protocols for combined modality therapy in childhood medulloblastoma.
Kaaijk P; Schouten-van Meeteren AY; Slotman BJ; Kaspers GJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):79-90. PubMed ID: 12597352
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin and cyclopamine combination in medulloblastoma.
Cancer Biol Ther; 2007 Feb; 6(2):133. PubMed ID: 17585408
[No Abstract] [Full Text] [Related]
16. Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.
Fendrich V; Rehm J; Waldmann J; Buchholz M; Christofori G; Lauth M; Slater EP; Bartsch DK
Ann Surg; 2011 Mar; 253(3):546-52. PubMed ID: 21239987
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified.
Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S
J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models.
Rozados VR; Hinrichsen LI; Binda MM; Gervasoni SI; Matar P; Bonfil RD; Scharovsky OG
Oncol Rep; 2008 May; 19(5):1205-11. PubMed ID: 18425377
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog antagonists cyclopamine and dihydroveratramine can be mistaken for each other in Veratrum album.
Wilson SR; Strand MF; Krapp A; Rise F; Herstad G; Malterud KE; Krauss S
J Pharm Biomed Anal; 2010 Nov; 53(3):497-502. PubMed ID: 20646889
[TBL] [Abstract][Full Text] [Related]
20. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy.
Tremblay MR; Nesler M; Weatherhead R; Castro AC
Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
